Literature DB >> 17629757

Lyme meningoradiculitis: prospective evaluation of biological diagnosis methods.

F Roux1, E Boyer, B Jaulhac, E Dernis, F Closs-Prophette, X Puéchal.   

Abstract

The symptoms of Lyme meningoradiculitis and the value of biological examinations in an endemic area were determined in a prospective study in which data were collected on all patients consecutively hospitalised for Lyme meningoradiculitis at our institution during an 18-month period. Specific antibody titres in the serum and cerebrospinal fluid (CSF) were determined by Vidas enzyme-linked-immunosorbent-assay (IgG + IgM), Dade-Behring enzyme immunoassay (EIA) (IgM; IgG) and Western blot analysis (IgG). We also searched for Borrelia burgdorferi in the CSF by PCR analysis and following culture on a specific medium. A control group was recruited, consisting of 16 consecutive patients who had been referred during the same period with suspected but not confirmed Lyme meningoradiculitis. Eleven patients were included. Borrelia EIA of the serum revealed that 40% of the patients had both elevated specific IgM titres and intrathecal synthesis of specific IgG; 40% of the patients was negative for IgM but had isolated intrathecal synthesis of IgG; 20% of the patients had elevated specific IgM titres without intrathecal synthesis of IgG. PCR analysis and the CSF culture were positive in one case only (B. garinii). The results of this study highlight the importance of systematic serological testing for B. burgdorferi in the CSF in the case of early neuroborreliosis suspicion, even in the absence of IgM serum antibodies, which was the case in 40% of the patients in the present study. Nevertheless, intrathecal anti-B. burgdorferi IgG synthesis, which remains the "gold standard" for the diagnosis of neuroborreliosis, was not detectable in 20% of the patients for whom diagnosis was subsequently confirmed by demonstration of specific serum IgM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17629757     DOI: 10.1007/s10096-007-0347-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-08-11       Impact factor: 17.586

Review 2.  Lyme borreliosis: basic science and clinical aspects.

Authors:  H W Pfister; B Wilske; K Weber
Journal:  Lancet       Date:  1994-04-23       Impact factor: 79.321

3.  Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis.

Authors:  J J Nocton; B J Bloom; B J Rutledge; D H Persing; E L Logigian; C H Schmid; A C Steere
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

4.  Comparison of the Borrelia DotBlot G, MarDx, and VIDAS enzyme immunoassays for detecting immunoglobulin G antibodies to Borrelia burgdorferi in human serum.

Authors:  Deborah J Jespersen; Thomas F Smith; Jon E Rosenblatt; Franklin R Cockerill
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

5.  Guidelines for the diagnosis of tick-borne bacterial diseases in Europe.

Authors:  P Brouqui; F Bacellar; G Baranton; R J Birtles; A Bjoërsdorff; J R Blanco; G Caruso; M Cinco; P E Fournier; E Francavilla; M Jensenius; J Kazar; H Laferl; A Lakos; S Lotric Furlan; M Maurin; J A Oteo; P Parola; C Perez-Eid; O Peter; D Postic; D Raoult; A Tellez; Y Tselentis; B Wilske
Journal:  Clin Microbiol Infect       Date:  2004-12       Impact factor: 8.067

6.  Comparison of two methods for detecting intrathecal synthesis of Borrelia burgdorferi-specific antibodies and PCR for diagnosis of Lyme neuroborreliosis.

Authors:  R Zbinden; D Goldenberger; G M Lucchini; M Altwegg
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

7.  Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis.

Authors:  M Karlsson; K Hovind-Hougen; B Svenungsson; G Stiernstedt
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

8.  Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis.

Authors:  H Tumani; G Nölker; H Reiber
Journal:  Neurology       Date:  1995-09       Impact factor: 9.910

9.  Diagnosis of spirochetal meningitis by enzyme-linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid.

Authors:  G T Stiernstedt; M Granström; B Hederstedt; B Sköldenberg
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

10.  The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis.

Authors:  A R Pachner; A C Steere
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

View more
  7 in total

1.  Humoral immune responses in patients with Lyme neuroborreliosis.

Authors:  Tjasa Cerar; Katarina Ogrinc; Franc Strle; Eva Ruzić-Sabljić
Journal:  Clin Vaccine Immunol       Date:  2010-02-17

2.  Neurologic manifestations of lyme disease.

Authors:  John J Halperin
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

3.  Diagnostic value of cytokines and chemokines in lyme neuroborreliosis.

Authors:  T Cerar; K Ogrinc; S Lotric-Furlan; J Kobal; S Levicnik-Stezinar; F Strle; E Ruzić-Sabljic
Journal:  Clin Vaccine Immunol       Date:  2013-08-14

Review 4.  The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis.

Authors:  M M G Leeflang; C W Ang; J Berkhout; H A Bijlmer; W Van Bortel; A H Brandenburg; N D Van Burgel; A P Van Dam; R B Dessau; V Fingerle; J W R Hovius; B Jaulhac; B Meijer; W Van Pelt; J F P Schellekens; R Spijker; F F Stelma; G Stanek; F Verduyn-Lunel; H Zeller; H Sprong
Journal:  BMC Infect Dis       Date:  2016-03-25       Impact factor: 3.090

5.  Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization.

Authors:  Philipp Schwenkenbecher; Refik Pul; Ulrich Wurster; Josef Conzen; Kaweh Pars; Hans Hartmann; Kurt-Wolfram Sühs; Ludwig Sedlacek; Martin Stangel; Corinna Trebst; Thomas Skripuletz
Journal:  BMC Infect Dis       Date:  2017-01-21       Impact factor: 3.090

6.  An Enzyme-Linked Immunosorbent Spot Assay Measuring Borrelia burgdorferi B31-Specific Interferon Gamma-Secreting T Cells Cannot Discriminate Active Lyme Neuroborreliosis from Past Lyme Borreliosis: a Prospective Study in the Netherlands.

Authors:  T van Gorkom; S U C Sankatsing; W Voet; D M Ismail; R H Muilwijk; M Salomons; B J M Vlaminckx; A W J Bossink; D W Notermans; J J M Bouwman; K Kremer; S F T Thijsen
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

7.  Case report: persistently seronegative neuroborreliosis in an immunocompromised patient.

Authors:  A Wagemakers; M C Visser; B de Wever; J W Hovius; N W C J van de Donk; E J Hendriks; L Peferoen; F F Muller; C W Ang
Journal:  BMC Infect Dis       Date:  2018-08-02       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.